During the development of RA, the migration of dendritic cells towards the site of inflammation is mediated by the chemokine CCR6 and increased CCR6 expression on the surface of DCs during RA pathogenesis, whose ligand CCL20 is highly expressed in synovial tissue. Here, CCR6 is linked to rheumatoid arthritis.